Cardiovascular Revascularization Medicine 16 (2015) 1
Contents lists available at ScienceDirect
Cardiovascular Revascularization Medicine
Editorial
When CRM meets CRT In January 1996, the first vascular brachytherapy course was held in Atlanta and was called radiation for restenosis. This course was the first of its kind to bring together cardiologists, radiation oncologists, physicists, and biologists to discuss an emerging field of vascular brachytherapy. A year later, when I moved to Washington, DC, I established the cardiovascular radiation therapy (CRT) course, which became the leading course in the field. In 1998, I was approached by Dr. Philip Rubin, who created and served as chairman of the Department of Radiation Oncology at the University of Rochester Medical Center from 1957 to 1996 and was the founder and editor-in-chief of the International Journal of Radiation Oncology, Biology, and Physics, also known as the Red Journal. Dr. Rubin came to me with the novel idea of dedicating a special journal to the multiple disciplines of cardiologists, radiation oncologists, physicists, and biologists. He then presented the idea to Glen Collins at the publishing company Elsevier, and Collins agreed to support the new journal, which was named Cardiovascular Radiation Medicine (CRM) and published four times a year. In 1999, the first issue of the journal was published, in which I served as its co-editor-in-chief with Dr. Rubin. The journal became the official journal of the CRT meeting and was mainly distributed to CRT meeting participants and academic institutions. When drug-eluting stents were approved for marketing in the United States, the interest in the field of vascular brachytherapy began to decline. Dr. Rubin passed the journal on to me, and it became a solely cardiovascular journal, with the CRM now standing for Cardiovascular Revascularization Medicine, including molecular interventions. Shortly
http://dx.doi.org/10.1016/j.carrev.2015.01.001 1553-8389/© 2015 Published by Elsevier Inc.
thereafter, the editorial office was moved to the MedStar Washington Hospital Center in Washington, DC, where it still sits today. Sadly, on September 24, 2014, Dr. Rubin died after a short illness. His passion to the field and desire to explore and discover therapeutic novelties will be remembered and serve as a beacon for the CRM journal. Meanwhile, the CRT acronym, which originally stood for Cardiovascular Radiation Therapy, was changed to stand for Cardiovascular Research Technologies. The CRT meeting continues to grow as a lead meeting for interventional cardiologists, with nearly 2,000 attendees a year and 14 concurrent sessions. This growth has impacted the expansion of the journal to include more diverse topics, an increase to 8 issues a year, and an increase in distribution. Finally, all first authors for manuscripts published in the CRM journal become associate faculty of the CRT meeting for the year of their publication. Today, it is my pleasure to present you with Issue 1, Volume 16, of the CRM journal for 2015. This issue comes with a revised cover and a new tagline, “Including valve and structural heart.” In this issue, you will find a variety of topics, including population science for patients presenting with ST segment elevation myocardial infarction and new technologies, such as stents, drug-coated balloons, transcatheter aortic valve replacement, and imaging. The link between CRT and the CRM journal is important for the growth of both of them, and together with CRTonline and the CRTonline app, they serve as useful tools to disseminate knowledge and education to the field. I hope that you will find an interest in this collaboration and will become an active partner in the CRT meeting and the CRM journal. Ron Waksman, MD
Contents lists available at ScienceDirect
Cardiovascular Revascularization Medicine
Editorial
When CRM meets CRT In January 1996, the first vascular brachytherapy course was held in Atlanta and was called radiation for restenosis. This course was the first of its kind to bring together cardiologists, radiation oncologists, physicists, and biologists to discuss an emerging field of vascular brachytherapy. A year later, when I moved to Washington, DC, I established the cardiovascular radiation therapy (CRT) course, which became the leading course in the field. In 1998, I was approached by Dr. Philip Rubin, who created and served as chairman of the Department of Radiation Oncology at the University of Rochester Medical Center from 1957 to 1996 and was the founder and editor-in-chief of the International Journal of Radiation Oncology, Biology, and Physics, also known as the Red Journal. Dr. Rubin came to me with the novel idea of dedicating a special journal to the multiple disciplines of cardiologists, radiation oncologists, physicists, and biologists. He then presented the idea to Glen Collins at the publishing company Elsevier, and Collins agreed to support the new journal, which was named Cardiovascular Radiation Medicine (CRM) and published four times a year. In 1999, the first issue of the journal was published, in which I served as its co-editor-in-chief with Dr. Rubin. The journal became the official journal of the CRT meeting and was mainly distributed to CRT meeting participants and academic institutions. When drug-eluting stents were approved for marketing in the United States, the interest in the field of vascular brachytherapy began to decline. Dr. Rubin passed the journal on to me, and it became a solely cardiovascular journal, with the CRM now standing for Cardiovascular Revascularization Medicine, including molecular interventions. Shortly
http://dx.doi.org/10.1016/j.carrev.2015.01.001 1553-8389/© 2015 Published by Elsevier Inc.
thereafter, the editorial office was moved to the MedStar Washington Hospital Center in Washington, DC, where it still sits today. Sadly, on September 24, 2014, Dr. Rubin died after a short illness. His passion to the field and desire to explore and discover therapeutic novelties will be remembered and serve as a beacon for the CRM journal. Meanwhile, the CRT acronym, which originally stood for Cardiovascular Radiation Therapy, was changed to stand for Cardiovascular Research Technologies. The CRT meeting continues to grow as a lead meeting for interventional cardiologists, with nearly 2,000 attendees a year and 14 concurrent sessions. This growth has impacted the expansion of the journal to include more diverse topics, an increase to 8 issues a year, and an increase in distribution. Finally, all first authors for manuscripts published in the CRM journal become associate faculty of the CRT meeting for the year of their publication. Today, it is my pleasure to present you with Issue 1, Volume 16, of the CRM journal for 2015. This issue comes with a revised cover and a new tagline, “Including valve and structural heart.” In this issue, you will find a variety of topics, including population science for patients presenting with ST segment elevation myocardial infarction and new technologies, such as stents, drug-coated balloons, transcatheter aortic valve replacement, and imaging. The link between CRT and the CRM journal is important for the growth of both of them, and together with CRTonline and the CRTonline app, they serve as useful tools to disseminate knowledge and education to the field. I hope that you will find an interest in this collaboration and will become an active partner in the CRT meeting and the CRM journal. Ron Waksman, MD
